| Financial Year |
March 31 2023 |
| Monetary Funds |
8,845,318,436.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,046,681.77 |
| Accounts Receivable |
7,013,674,574.71 |
| Advances to Suppliers |
9,974,167,274.31 |
| Other Receivables |
2,215,838,566.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,512,646,905.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
405,285,076.30 |
| Total Current Assets |
30,945,154,560.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
321,617,838.78 |
| Long-term Equity Investment |
2,482,384,151.49 |
| Investment Properties |
894,512,556.83 |
| Fixed Assetes |
7,665,110,133.28 |
| Under-construction Projects |
5,133,904,385.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,293,172,194.16 |
| R&D expenses |
72,850,581.11 |
| Goodwill |
808,904,519.96 |
| Long-Term Deferred and Prepaid Expenses |
4,471,639.77 |
| Deferred Income Tax Assets |
1,049,164,100.14 |
| Other Non-Current Assets |
5,734,327,864.53 |
| Sub-Total of Non-Current Assets |
27,940,328,557.25 |
| Total Assets |
58,885,483,117.32 |
| Short-Term Loans |
7,866,427,496.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,894,932,396.34 |
| Accounts Received In Advance |
378,797,909.05 |
| Employee Compensation Payable |
135,229,973.10 |
| Taxes Payable |
304,967,654.99 |
| Interest Payable |
3,364,820,825.10 |
| Dividend Payable |
2,223,704.00 |
| Other payables |
5,025,979,986.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,319,321,366.29 |
| Other Current Liabilities |
528,492,398.21 |
| Sub-Total of Current Liabilities |
33,706,903,546.06 |
| Long-term Loans |
648,512,000.76 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
373,982,020.51 |
| Special Payable |
-- |
| Estimatied Liabilities |
66,915,887.02 |
| Deferred Income Tax Liabilities |
54,888,206.13 |
| Other Non-Current Liabilities |
108,000,000.00 |
| Sub-Total of Non-Current Liabilities |
1,739,274,140.01 |
| Total Liabilities |
35,446,177,686.07 |
| Paid-In Capital(Or Share Stock) |
5,632,749,948.00 |
| Capital Surplus |
21,684,140,052.27 |
| Surplus Reserve |
245,507,019.95 |
| LESS:Treasury Stock |
4,422,320.00 |
| Undistributed Profits |
-5,263,862,652.29 |
| Minority Stockholder's Interest |
1,021,028,071.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
22,418,277,359.55 |
| Owner's Equity（Stockholder's Equity） |
23,439,305,431.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
58,885,483,117.32 |
